Phlebitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients were male or female, gained approval from the Ethics Committee of our hospital, and they or their representatives signed informed consent for voluntary participation in this study; (2) The preset puncture site had no history of radiotherapy, venous thrombosis, and vascular surgery, as well as absence of rash, skin damage, ecchymosis, scar, inflammation, and induration; (3) Showed normal coagulation function; (4) Blood routine examination revealed platelet content >100×10^9; (5) The peripheral veins were adequately filled and were elastic with the absence of recurrent venous catheterization history; (6) No history of allergies.
Exclusion criteria
Exclusion criteria: (1) Patients who did not fulfill the above inclusion criteria; (2) Undergone bilateral breast cancer surgery within 2 years; (3) Weakness in hemiplegic limbs or upper limb at puncture side; (4) Participated in other clinical trials of drugs within 6 months (not beyond washout period).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Phlebitis incidence rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Internal diameter of the catheter;Success rate of first set tube; | — |
Countries
China
Contacts
the First Affiliated Hospital of Zhejiang Chinese Medical University